Press Releases
 
Cytomegalovirus Retinitis Market Trends, Size, Growth and Demand, 2023

United States, 8 December 2017 -- One of the major trends noticed in the cytomegalovirus retinitis market is usage of off-label drugs for the treatment of cytomegalovirus retinitis.

Innovation of products focusing on better efficacy, growing demographics and growing economies in the developing countries, such as China and India, are some of the opportunities for global cytomegalovirus retinitis market.

Cytomegalovirus retinitis is eye disease caused due to retina inflammation of eye. The causative agent of the disease is cytomegalovirus, a herpes virus that affects the photosensitive cells of retina. After affecting the retina, the disease spreads from one eye to another eye, which can lead to blindness, if left untreated. Photophobia, blurred vision, seeing floaters and blind spots are the symptoms of cytomegalovirus retinitis. Cytomegalovirus retinitis usually affects people with weak immune system, including HIV affected patients. Various forms of cytomegalovirus retinitis medication are solutions, capsules, tablets and implants.

To know more about Cytomegalovirus Retinitis Market: https://www.psmarketresearch.com/market-analysis/cytomegalovirus-retinitis-market

Cytomegalovirus retinitis is an emergency situation because if a black spot in the visual field appears once, the disease cannot be cured due to its permanent in nature. If posterior pole is involved, it leads to approximately one half of incident visual acuity loss. Ophthalmology is the branch of medical science that deals with the study and management of physiology, anatomy and the diseases related to the human eye. The vision loss and incidence of eye disorders are becoming a major public health issues which include various eye diseases such as glaucoma, age-related macular degeneration, cataract, diabetic macular edema, retinal detachment, ocular hypertension, bulging eyes, refractive errors and uveitis. Active cytomegalovirus retinitis is generally treated by uveitis or ocular immunology specialist. Fomivirsen was the first antisense drug approved by the U.S. Food and Drug Administration (FDA) as an intraocular injection for curing cytomegalovirus retinitis. As the virus creates a worse effect to vision, it is generally treated by a vitreoretinal surgeon with the help of antivirals, such as ganciclovir or foscarnet, which can be taken orally or directly into the eye.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/cytomegalovirus-retinitis-market/report-sample

Some of the major competitors of global cytomegalovirus retinitis market are, Shire Plc, F. Hoffmann-La Roche AG, Hospira Inc., Chimerix Inc., Gilead Sciences Inc., pSivida, Auritec Pharmaceuticals Inc., Sanofi S.A., and Isis Pharmaceuticals Inc.

# # #


Submitted by Jacob, P&S Market Research on Friday, 8 December 2017 at 6:18 AM
Category: Health Care & Medical
 
Related News

The best cosmetic dentistry Los Angeles
Saturday, 26 May 2018

Cell Expansion Market rising from US$7.7 bn in 2015 to US$26 bn by the end of the forecast period 20
Friday, 25 May 2018

Ductless Fume Hoods Market Size Significant Growth Opportunities to Expand During 2017 - 2025
Friday, 25 May 2018

Kana Post Delivers Innovative Tested Cannabis Products At The Cheapest Prices In Canada
Friday, 25 May 2018

Bipolar Disorder Therapeutics Market Growth to Remain Stable During the Period 2017 - 2025
Friday, 25 May 2018

Related Events

Biofilms 8 Conference
Sunday, 27 May 2018

8th International Conference on Case Reports 2018
Monday, 28 May 2018

CRISPR Agbio And NBT Congress Summit
Tuesday, 29 May 2018

Paris Healthcare Week
Tuesday, 29 May 2018

T3: Trials, Tech and Transformation
Wednesday, 30 May 2018

Latest News

Why Silk Pillowcases are the Answer to Your Beauty Woes
Monday, 28 May 2018

Next Level Opens Control4 Certified Showroom in Phoenix, Arizona
Monday, 28 May 2018

Tips on Buying Window Blinds
Monday, 28 May 2018

Rackspace Expands to Strengthen IT as a Service Capabilities in Asia
Monday, 28 May 2018

Hurry to Buy Up to 9% off runescape gold from Rsorder for RS Classic Until June 8
Monday, 28 May 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Monday, 28 May 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Biofilms 8 Conference
  • Wolf Beach
  • 8th International Conference on Case Reports 2018
  • Belfast Summit on Global Food Integrity
  • Cyprus Gaming Show Conference, Cyprus 2018

  • Latest Jobs
    Sorry, there are currently no entries posted here.